INVESTOR ACTION ALERT: Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with losses of $100,000 to contact the company

LOS ANGELES, CA / ACCESSWIRE / April 21, 2024 / The Schall Law Firm, a national shareholder rights law firm, reminds investors of a class action lawsuit against Anavex Life Sciences Corp. (“Anavex” or “the Company”) (NASDAQ:AVXL) for violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between February 1, 2022 and January 1, 2024, inclusive (the “Class Period”) are encouraged to contact the firm before May 13, 2024.

If you are a shareholder and have suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights, free of charge. You can also reach us via the company’s website at www.schallfirm.com, or by email at [email protected].

In this case, the class has not yet been certified and until certification occurs, you will not be represented by an attorney. If you choose to take no action, you may remain an absent class member.

According to the complaint, the company made false and misleading statements to the marketplace. Anavex gave investors a materially inaccurate view of its research program and the likelihood that product candidate blarcamesine would succeed in the “Excellence” Phase II/Phase III trial. The company subsequently announced the use of the “MMRM” statistical methodology in the Excellence study to analyze the study’s data, which ultimately failed to achieve statistical significance. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Anavex, investors suffered.

The Schall Law Firm represents investors worldwide and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered attorney advertising in some jurisdictions under applicable law and ethical rules.

CONTACT:

Schall law firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE: Schall law firm

View the original press release on accesswire.com